JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.57, sa.2, ss.344-348, 2006 (SCI-Expanded)
Objectives: 1-(1-Naphthylmethyl)-piperazine (NMP) has been shown to reverse multidrug resistance (MDR) in Escherichia coli overexpressing RND type efflux pumps, but there is no data on its activity in Enterobacteriaceae other than E. coli.